Underpinning Voyager’s mission is its trademark AAV capsid-discovery platform ... which is the naturally occurring AAV serotype that is currently understood to have the best penetration of ...

With this ground-breaking invention, the Vericheck ddPCR Empty-Full Capsid Kit streamlines the AAV development to produce dependable results. Using ddPCR technology, obtaining absolute ...

In this talk, David Apiyo, Manager of Application Development at Sartorius (Göttingen, Germany), proposes a method that extends the use of AAVX biosensors to determine empty-to-full capsid ratios.

With their increasing adoption, precise tools are vital for quantifying AAV capsid titers and detecting anti-AAV antibodies to ensure the safety, efficacy and proper dosing of therapies. This ...

in patients with severe Crigler-Najjar syndrome and pre-formed antibodies to AAV serotype 8 (AAV8). Søren Tulstrup, President and CEO, Hansa Biopharma said, “We know that anti-AAV antibodies ...

(PRNewsFoto/Astellas Pharma Inc.) Sandy Macrae, Chief Executive Officer, Sangamo "We strongly believe in the potential of STAC-BBB, our industry-leading, intravenously delivered AAV capsid, to ...

Coave's proprietary ALIGATER platform enables specific retargeting of AAV vectors to human receptors via a one-step chemical conjugation of peptide-based ligands at the surface of the capsid, ...